We are live on ! Find out more
ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

169 hedge funds and large institutions have $2.42B invested in Intercept Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 39 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 39

7% less funds holding

Funds holding: 181 → 169 (-12)

20% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 49

21% less capital invested

Capital invested by funds: $3.05B → $2.42B (-$632M)

42% less call options, than puts

Call options by funds: $56.6M | Put options by funds: $96.8M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
169
Holders Change
-12
Holders Change %
-6.63%
% of All Funds
4.51%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
39
Increased
74
Reduced
39
Closed
49
Calls
$56.6M
Puts
$96.8M
Net Calls
-$40.2M
Net Calls Change
+$29.3M

Top Buyers

1
First Trust Advisors
First Trust Advisors
Illinois
+$49.1M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$48.6M
3
Franklin Resources
Franklin Resources
California
+$48.3M
4
AGA
Altrinsic Global Advisors
Connecticut
+$46.4M
5
BFA
BlackRock Fund Advisors
California
+$45.6M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$43.2M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$42.7M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$21.7M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$15.5M
5
Nomura Holdings
Nomura Holdings
Japan
-$12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$500M +$3.93M +21,258 +0.7%
O
2
OrbiMed
New York
$232M – – –
CG
3
Carmignac Gestion
France
$223M +$18.8M +101,555 +8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$118M +$4.7M +25,434 +3%
Franklin Resources
5
Franklin Resources
California
$92.1M +$48.3M +261,350 +79%
Capital World Investors
6
Capital World Investors
California
$78.4M -$43.2M -233,942 -32%
Jennison Associates
7
Jennison Associates
New York
$73.1M +$38.4M +208,146 +80%
Millennium Management
8
Millennium Management
New York
$70.6M +$27.8M +150,301 +50%
CWAM
9
Columbia Wanger Asset Management
Illinois
$61.4M +$38.9M +210,550 +115%
BFA
10
BlackRock Fund Advisors
California
$53.7M +$45.6M +247,026 +254%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$53.2M +$4.57M +24,732 +8%
BIT
12
BlackRock Institutional Trust
California
$49.8M +$2.04M +11,047 +4%
AGA
13
Altrinsic Global Advisors
Connecticut
$47.1M +$46.4M +250,969 +494%
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$46.8M +$48.6M +262,900 +705%
First Trust Advisors
15
First Trust Advisors
Illinois
$43.2M +$49.1M +265,900 +2,356%
State Street
16
State Street
Massachusetts
$41.4M +$12.5M +67,757 +34%
FAM
17
Fred Alger Management
New York
$40.5M +$33.3M +180,162 +226%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$40M -$1.18M -6,384 -2%
SAM
19
Sectoral Asset Management
Quebec, Canada
$28.4M +$19.2M +103,954 +133%
Credit Agricole
20
Credit Agricole
France
$27.8M +$32.7M +177,018 New
Norges Bank
21
Norges Bank
Norway
$19.2M – – –
UBS AM
22
UBS AM
Illinois
$19.1M +$5.41M +29,300 +31%
Adage Capital Partners
23
Adage Capital Partners
Massachusetts
$18.7M +$14.6M +79,000 +193%
Invesco
24
Invesco
Georgia
$18.4M +$6.66M +36,064 +44%
Morgan Stanley
25
Morgan Stanley
New York
$17.1M -$2.82M -15,282 -12%
1
2 3 4 5

ICPT Hedge Fund Activity: Q4 2014 in Review

169 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q4 2014, worth a combined $2.42B — down 21% from $3.05B a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of ICPT and 39 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 74 added.

The largest buyer was First Trust Advisors, adding an estimated $49.1M. The largest seller was Capital World Investors, cutting an estimated $43.2M.

  • 169 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q4 2014, down from 181 in Q3 2014.
  • Funds reported $2.42B of Intercept Pharmaceuticals, Inc. stock for Q4 2014, down 21% quarter-over-quarter.
  • 39 funds opened new Intercept Pharmaceuticals, Inc. positions in Q4 2014 and 49 closed out, a net change of -10 holders.
  • The largest Intercept Pharmaceuticals, Inc. buyer in Q4 2014 was First Trust Advisors, an estimated $49.1M added.
  • The largest Intercept Pharmaceuticals, Inc. seller in Q4 2014 was Capital World Investors, an estimated $43.2M sold.

Based on aggregated 13F filings for Q4 2014.